Each week, many millions are invested into life sciences startups. For example, Stroma Medical – a laser therapy company that claims it can swap your eye color from brown to blue – is in the midst of clinical trials and has raised more cash. Here’s how Stroma describes the post-laser color change process:
For the first week or so following the procedure, the irises will get darker. Thereafter, they will grow progressively lighter, revealing the underlying natural blue color. The full color change process should take two to four weeks following the procedure.
Neat. So we’re keeping track of these startup moves for you, based on regulatory filings reported to the SEC. Here are the new funding notices from Nov. 3 to 7:
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Biotech
Abeona Therapeutics – Cleveland, Ohio
- $3.6 million in equity raised of a proposed $5 million round
- Developing treatments for orphan childhood lysosomal storage disease. Its lead candidates, ABX-A and ABX-B, treat Sanfilippo Type A and Type B disease, respectively.
Appco Pharma – Piscataway, New Jersey
- No cash yet raised of a proposed $5 million equity round
- Generic drugmaker.
AzurRx BioPharma – New York, New York
- $284,000 of a proposed $7 million debt financing raised
- Developing non-systemic, recombinant protein therapies to treat gastrointestinal conditions and hospital-acquired infections.
Diabetomics – Hillsboro, Oregon
- $2.5 million in equity raised of a proposed $15 million round
- Dried spot blood assessments of diabetes risk, progression and complications. Provides advanced diabetes, autoimmune diabetes, preeclampsia and gestational diabetes profiles.
MDRejuvena – San Diego, California
- $250,000 in equity raised of a proposed $5.1 million round
- Not much info here, but likely a cosmeceutical company. Notably, it’s backed by San Diego biotech vet David Hale.
Paragon Bioservices – Baltimore, Maryland
- $13.5 million in equity raised
- Biologics and vaccine CRO and CMO, working in preclinical, Phase I and Phase II research.
- More from MedCity News
Theranostics Health – Rockville, Maryland
- $855,000 in equity raised of a proposed $1 million round
- Develops ways to measure the activation of signaling pathways necessary in molecular targeted therapies and companion diagnostics.
- More from MedCity News
HealthIT
Bio-Tech Medical Software – Ft. Lauderdale, Florida
- No cash yet raised of a proposed $5 million round
- Biometric, real-time, anonymous prescription monitoring database that can protect patient privacy while at the same time providing law enforcement real-time intelligence to help companies uphold the law.
Click Therapeutics – New York, New York
- $1.1 million in debt of a proposed $3.1 million raised
- Digital therapeutics for patients with neuropsychiatric dysfunction.
Medical Devices
EyeBrain Medical – South Dakota
- $1 million in equity raised
- Its glasses are designed to reduce chronic migraines without surgery or medication.
- More from MedCity News
Neuro Kinetics – Pittsburgh, Pennsylvania
- $212,241 in debt raised of a proposed $1 million round
- Uses eye-tracking technology for noninvasive neuro-otologic diagnostic testing.
Stroma Medical – Laguna Beach, California
- $3.4 million in equity raised of a proposed $4 million round
- Uses lasers to change eye color